111 – 120 of 143
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2020
- 
                        Mark
        The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer
    
    - Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration
    
    - Contribution to journal › Article
 
- 
                        Mark
        Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
    
    - Contribution to journal › Article
 
- 
                        Mark
        Afadin cooperates with Claudin-2 to promote breast cancer metastasis
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Characterization of male breast cancer : Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
    
    - Contribution to journal › Article
 
